Eltahla AA - Search Results

1

Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance.

Eltahla AA, Luciani F, White PA, Lloyd AR, Bull RA. Eltahla AA, et al. Viruses. 2015 Sep 29;7(10):5206-24. doi: 10.3390/v7102868. Viruses. 2015. PMID: 26426038 Free PMC article. Review.

2

Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents.

Eltahla AA, Rodrigo C, Betz-Stablein B, Grebely J, Applegate T, Luciani F, Schinkel J, Dore GJ, Page K, Bruneau J, Morris MD, Cox AL, Kim AY, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Lloyd AR, Bull RA; InC3 Study Group. Eltahla AA, et al. J Viral Hepat. 2017 Jan;24(1):37-42. doi: 10.1111/jvh.12615. Epub 2016 Sep 25. J Viral Hepat. 2017. PMID: 27666440 Free PMC article.

3

A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.

Eltahla AA, Lackovic K, Marquis C, Eden JS, White PA. Eltahla AA, et al. J Biomol Screen. 2013 Oct;18(9):1027-34. doi: 10.1177/1087057113489883. Epub 2013 May 24. J Biomol Screen. 2013. PMID: 23708123

4

Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.

Eltahla AA, Lim KL, Eden JS, Kelly AG, Mackenzie JM, White PA. Eltahla AA, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3115-23. doi: 10.1128/AAC.02799-13. Epub 2014 Mar 17. Antimicrob Agents Chemother. 2014. PMID: 24637690 Free PMC article.

5

Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders.

Eltahla AA, Tay E, Douglas MW, White PA. Eltahla AA, et al. Antimicrob Agents Chemother. 2014 Dec;58(12):7215-24. doi: 10.1128/AAC.03699-14. Epub 2014 Sep 22. Antimicrob Agents Chemother. 2014. PMID: 25246395 Free PMC article.

6

A method for near full-length amplification and sequencing for six hepatitis C virus genotypes.

Bull RA, Eltahla AA, Rodrigo C, Koekkoek SM, Walker M, Pirozyan MR, Betz-Stablein B, Toepfer A, Laird M, Oh S, Heiner C, Maher L, Schinkel J, Lloyd AR, Luciani F. Bull RA, et al. Among authors: eltahla aa. BMC Genomics. 2016 Mar 17;17:247. doi: 10.1186/s12864-016-2575-8. BMC Genomics. 2016. PMID: 26988550 Free PMC article.

7

Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment.

Eltahla AA, Leung P, Pirozyan MR, Rodrigo C, Grebely J, Applegate T, Maher L, Luciani F, Lloyd AR, Bull RA. Eltahla AA, et al. Sci Rep. 2017 Jan 31;7:41719. doi: 10.1038/srep41719. Sci Rep. 2017. PMID: 28139734 Free PMC article.

8

Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies.

Walker MR, Leung P, Eltahla AA, Underwood A, Abayasingam A, Brasher NA, Li H, Wu BR, Maher L, Luciani F, Lloyd AR, Bull RA. Walker MR, et al. Among authors: eltahla aa. Sci Rep. 2019 Sep 16;9(1):13300. doi: 10.1038/s41598-019-49454-w. Sci Rep. 2019. PMID: 31527718 Free PMC article.

9

Understanding the Determinants of BnAb Induction in Acute HCV Infection.

Underwood AP, Walker MR, Brasher NA, Eltahla AA, Maher L, Luciani F, Lloyd AR, Bull RA. Underwood AP, et al. Among authors: eltahla aa. Viruses. 2018 Nov 21;10(11):659. doi: 10.3390/v10110659. Viruses. 2018. PMID: 30469363 Free PMC article.

10

B cell immunodominance in primary hepatitis C virus infection.

Brasher NA, Eltahla AA, Underwood A, Boo I, Rizzetto S, Walker MR, Rodrigo C, Luciani F, Maher L, Drummer HE, Tedla N, Lloyd AR, Bull RA. Brasher NA, et al. Among authors: eltahla aa. J Hepatol. 2020 Apr;72(4):670-679. doi: 10.1016/j.jhep.2019.11.011. Epub 2019 Nov 28. J Hepatol. 2020. PMID: 31785346 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page